Naraporn Somboonna Selected Research

fluorescein isothiocyanate dextran

6/2022	Candida Worsens Klebsiella pneumoniae Induced-Sepsis in a Mouse Model with Low Dose Dextran Sulfate Solution through Gut Dysbiosis and Enhanced Inflammation.
2/2022	Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by Candida Administration through a Synergy of Uremic Toxin, Lipopolysaccharide, and (1➔3)-β-D-Glucan, but Is Attenuated by Lacticaseibacillus rhamnosus L34.
12/2021	Lactiplantibacillus plantarum dfa1 Outperforms Enterococcus faecium dfa1 on Anti-Obesity in High Fat-Induced Obesity Mice Possibly through the Differences in Gut Dysbiosis Attenuation, despite the Similar Anti-Inflammatory Properties.
1/2021	Candida Administration Worsens Uremia-Induced Gut Leakage in Bilateral Nephrectomy Mice, an Impact of Gut Fungi and Organismal Molecules in Uremia.
1/2021	Increased susceptibility to dextran sulfate-induced mucositis of iron-overload β-thalassemia mice, another endogenous cause of septicemia in thalassemia.
1/2021	Lactobacillus rhamnosus attenuates Thai chili extracts induced gut inflammation and dysbiosis despite capsaicin bactericidal effect against the probiotics, a possible toxicity of high dose capsaicin.
1/2020	Additional Candida albicans administration enhances the severity of dextran sulfate solution induced colitis mouse model through leaky gut-enhanced systemic inflammation and gut-dysbiosis but attenuated by Lactobacillus rhamnosus L34.
1/2019	Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naraporn Somboonna Research Topics

Disease

9	Inflammation (Inflammations) 06/2022 - 01/2020
7	Endotoxemia 06/2022 - 01/2020
7	Sepsis (Septicemia) 06/2022 - 01/2017
7	Dysbiosis 06/2022 - 01/2020
5	Infections 02/2022 - 01/2019
4	Bacteremia 06/2022 - 01/2021
4	Weight Loss (Weight Reduction) 01/2021 - 01/2019
3	Mucositis 06/2022 - 01/2021
3	Colitis 06/2022 - 01/2020
3	Proteinuria 02/2022 - 01/2020
2	Uremia 02/2022 - 01/2021
2	Obesity 12/2021 - 01/2021
2	Iron Overload 01/2021 - 01/2020
2	Diarrhea 01/2021 - 01/2020
2	Thalassemia 01/2021 - 01/2020
2	Candidemia 01/2018 - 01/2017
2	Acne Vulgaris 09/2017 - 01/2017
1	Fibrosis (Cirrhosis) 02/2022
1	Neoplasms (Cancer) 02/2022
1	Body Weight (Weight, Body) 12/2021
1	Eye Infections 11/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Herpes Zoster 01/2021
1	Clostridium Infections 01/2021
1	Foodborne Diseases 01/2020
1	Hemochromatosis (Bronze Diabetes) 01/2020
1	beta-Thalassemia (Cooley's Anemia) 01/2020
1	Fungemia 01/2020
1	Eye Diseases (Eye Disease) 01/2019
1	Trachoma 01/2019
1	Atopic Dermatitis (Atopic Eczema) 01/2019
1	Lymphogranuloma Venereum 01/2011
1	Paraplegia (Spastic Paraplegia) 12/2006
1	Patent Ductus Arteriosus 12/2006
1	Thrombosis (Thrombus) 12/2006
1	Soft Tissue Infections 05/2004

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 06/2022 - 01/2017
8	fluorescein isothiocyanate dextranIBA 06/2022 - 01/2019
5	Dextran SulfateIBA 06/2022 - 01/2020
5	SolutionsIBA 06/2022 - 01/2020
5	LipopolysaccharidesIBA 02/2022 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
2	EndotoxinsIBA 06/2022 - 01/2021
2	isothiocyanic acidIBA 02/2022 - 01/2021
2	CreatinineIBA 02/2022 - 01/2020
2	Fluorescein (Funduscein)FDA LinkGeneric 02/2022 - 01/2021
2	Tryptophan (L-Tryptophan)FDA Link 11/2021 - 01/2019
2	IronIBA 01/2021 - 01/2020
2	EnzymesIBA 01/2021 - 01/2021
2	GlobinsIBA 01/2021 - 01/2020
2	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 09/2017 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 01/2011 - 05/2004
1	beta-GlucansIBA 06/2022
1	Caspase 3 (Caspase-3)IBA 06/2022
1	Alanine Transaminase (SGPT)IBA 02/2022
1	Uremic ToxinsIBA 02/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 02/2022
1	IndicanIBA 02/2022
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	Bacterial DNAIBA 02/2022
1	DNA (Deoxyribonucleic Acid)IBA 02/2022
1	CholesterolIBA 12/2021
1	InterleukinsIBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	Capsaicin (Zostrix)FDA Link 01/2021
1	OccludinIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Chemokine CXCL2IBA 01/2021
1	LipidsIBA 01/2021
1	MucinsIBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	pristane (pristan)IBA 09/2020
1	Therapeutic UsesIBA 09/2020
1	Enterotoxins (Enterotoxin)IBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	indoleIBA 01/2019
1	Saline SolutionIBA 01/2017
1	Leukocidins (Leukocidin)IBA 05/2004

Therapy/Procedure

4	Oral Administration 01/2021 - 01/2017
3	Ligation 02/2022 - 01/2017
3	Punctures 02/2022 - 01/2017
1	Nephrectomy 01/2021
1	Thoracotomy 12/2006
1	Sutures (Suture) 12/2006
1	Laminectomy 12/2006